S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   420.93 (-0.59%)
AAPL   165.98 (-0.63%)
MSFT   403.65 (-0.15%)
META   494.29 (-1.50%)
GOOGL   154.50 (-0.97%)
AMZN   177.59 (-0.91%)
TSLA   148.60 (-0.89%)
NVDA   837.10 (-1.13%)
AMD   151.34 (-2.41%)
NIO   3.86 (-3.50%)
BABA   68.58 (-0.44%)
T   16.34 (+0.06%)
F   12.15 (+0.75%)
MU   109.95 (-1.77%)
GE   152.24 (-0.46%)
CGC   7.89 (+0.77%)
DIS   111.98 (-0.40%)
AMC   2.85 (-2.40%)
PFE   25.43 (+0.16%)
PYPL   62.14 (+0.06%)
XOM   119.73 (+1.02%)
S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   420.93 (-0.59%)
AAPL   165.98 (-0.63%)
MSFT   403.65 (-0.15%)
META   494.29 (-1.50%)
GOOGL   154.50 (-0.97%)
AMZN   177.59 (-0.91%)
TSLA   148.60 (-0.89%)
NVDA   837.10 (-1.13%)
AMD   151.34 (-2.41%)
NIO   3.86 (-3.50%)
BABA   68.58 (-0.44%)
T   16.34 (+0.06%)
F   12.15 (+0.75%)
MU   109.95 (-1.77%)
GE   152.24 (-0.46%)
CGC   7.89 (+0.77%)
DIS   111.98 (-0.40%)
AMC   2.85 (-2.40%)
PFE   25.43 (+0.16%)
PYPL   62.14 (+0.06%)
XOM   119.73 (+1.02%)
S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   420.93 (-0.59%)
AAPL   165.98 (-0.63%)
MSFT   403.65 (-0.15%)
META   494.29 (-1.50%)
GOOGL   154.50 (-0.97%)
AMZN   177.59 (-0.91%)
TSLA   148.60 (-0.89%)
NVDA   837.10 (-1.13%)
AMD   151.34 (-2.41%)
NIO   3.86 (-3.50%)
BABA   68.58 (-0.44%)
T   16.34 (+0.06%)
F   12.15 (+0.75%)
MU   109.95 (-1.77%)
GE   152.24 (-0.46%)
CGC   7.89 (+0.77%)
DIS   111.98 (-0.40%)
AMC   2.85 (-2.40%)
PFE   25.43 (+0.16%)
PYPL   62.14 (+0.06%)
XOM   119.73 (+1.02%)
S&P 500   5,015.60 (+0.09%)
DOW   37,961.30 (+0.49%)
QQQ   420.93 (-0.59%)
AAPL   165.98 (-0.63%)
MSFT   403.65 (-0.15%)
META   494.29 (-1.50%)
GOOGL   154.50 (-0.97%)
AMZN   177.59 (-0.91%)
TSLA   148.60 (-0.89%)
NVDA   837.10 (-1.13%)
AMD   151.34 (-2.41%)
NIO   3.86 (-3.50%)
BABA   68.58 (-0.44%)
T   16.34 (+0.06%)
F   12.15 (+0.75%)
MU   109.95 (-1.77%)
GE   152.24 (-0.46%)
CGC   7.89 (+0.77%)
DIS   111.98 (-0.40%)
AMC   2.85 (-2.40%)
PFE   25.43 (+0.16%)
PYPL   62.14 (+0.06%)
XOM   119.73 (+1.02%)

Black Diamond Therapeutics (BDTX) News Today

$5.21
-0.09 (-1.70%)
(As of 09:39 AM ET)
SourceHeadline
MarketBeat logoCognition Therapeutics (NASDAQ:CGTX) and Black Diamond Therapeutics (NASDAQ:BDTX) Head to Head Review
americanbankingnews.com - April 17 at 4:10 AM
marketbeat.com logoShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Expands By 12.7%
marketbeat.com - April 14 at 4:21 PM
MarketBeat logoBlack Diamond Therapeutics, Inc. Expected to Earn Q1 2024 Earnings of ($0.41) Per Share (NASDAQ:BDTX)
americanbankingnews.com - April 12 at 1:20 AM
globenewswire.com logoBlack Diamond Therapeutics Announces Changes to Board of Directors
globenewswire.com - April 11 at 8:00 AM
marketbeat.com logoBrokers Set Expectations for Black Diamond Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:BDTX)
marketbeat.com - April 11 at 7:10 AM
MarketBeat logoWedbush Increases Black Diamond Therapeutics (NASDAQ:BDTX) Price Target to $16.00
americanbankingnews.com - April 9 at 3:12 AM
finance.yahoo.com logoWall Street Analysts Predict a 129.25% Upside in Black Diamond (BDTX): Here's What You Should Know
finance.yahoo.com - April 8 at 3:09 PM
marketbeat.com logoBlack Diamond Therapeutics (NASDAQ:BDTX) Price Target Raised to $16.00 at Wedbush
marketbeat.com - April 8 at 11:37 AM
globenewswire.com logoBlack Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
globenewswire.com - April 7 at 6:00 PM
globenewswire.com logoBlack Diamond Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com - April 3 at 8:00 AM
marketbeat.com logoEquities Analysts Issue Forecasts for Black Diamond Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:BDTX)
marketbeat.com - March 20 at 5:46 AM
marketbeat.com logoBlack Diamond Therapeutics (NASDAQ:BDTX) Earns Buy Rating from HC Wainwright
marketbeat.com - March 18 at 5:32 PM
marketbeat.com logoBlack Diamond Therapeutics, Inc. Forecasted to Earn FY2024 Earnings of ($1.76) Per Share (NASDAQ:BDTX)
marketbeat.com - March 18 at 2:04 AM
marketbeat.com logoBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Decline in Short Interest
marketbeat.com - March 18 at 1:54 AM
finance.yahoo.com logoBlack Diamond Therapeutics Inc (BDTX) Reports Q4 and Full Year 2023 Financials, Advances ...
finance.yahoo.com - March 14 at 9:00 AM
marketbeat.com logoBlack Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Reaffirmed by Wedbush
marketbeat.com - March 13 at 10:27 AM
globenewswire.com logoBlack Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
globenewswire.com - March 12 at 8:00 AM
globenewswire.com logoBlack Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024
globenewswire.com - March 5 at 4:30 PM
marketbeat.com logoBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Sees Large Drop in Short Interest
marketbeat.com - March 2 at 2:31 AM
seekingalpha.com logoBDTX Black Diamond Therapeutics, Inc.
seekingalpha.com - February 29 at 6:00 PM
globenewswire.com logoBlack Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
globenewswire.com - February 28 at 8:00 AM
marketbeat.com logoBarclays PLC Acquires 197,895 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)
marketbeat.com - February 21 at 4:13 AM
uk.investing.com logoBlack Diamond Therapeutics Inc (BDTX)
uk.investing.com - February 16 at 8:39 PM
marketbeat.com logoBlack Diamond Therapeutics (NASDAQ:BDTX) Trading Up 2.6%
marketbeat.com - February 13 at 2:35 AM
wsj.com logoBlack Diamond Therapeutics Inc.
wsj.com - January 24 at 2:19 AM
finance.yahoo.com logoBlack Diamond Therapeutics Announces Corporate Update and Expected 2024 Milestones
finance.yahoo.com - January 4 at 8:42 AM
marketbeat.com logoShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Increases By 6.4%
marketbeat.com - January 3 at 7:00 AM
msn.com logoBlack Diamond reports positive topline data for GBM drug
msn.com - December 14 at 5:23 PM
markets.businessinsider.com logoBuy Rating Reaffirmed for Black Diamond Therapeutics Amid Promising BDTX-1535 Trial Results and Strategic Development
markets.businessinsider.com - December 14 at 12:22 PM
finance.yahoo.com logoBlack Diamond Therapeutics Announces Topline Results from Phase 1 Dose Escalation Trial of BDTX-1535 in Patients with Recurrent GBM
finance.yahoo.com - December 13 at 7:21 AM
finance.yahoo.com logoWith 58% ownership, Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) boasts of strong institutional backing
finance.yahoo.com - December 5 at 9:22 AM
washingtonpost.com logoSolitario: Q3 Earnings Snapshot
washingtonpost.com - November 9 at 7:31 AM
finance.yahoo.com logoBlack Diamond Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - November 6 at 8:16 AM
finance.yahoo.com logoBlack Diamond Therapeutics Inc (BDTX) Reports Q3 2023 Financial Results and Corporate Update
finance.yahoo.com - November 6 at 8:16 AM
morningstar.com logoBlack Diamond Therapeutics Inc Ordinary Shares BDTX
morningstar.com - October 31 at 2:14 PM
markets.businessinsider.com logoAnalysts’ Top Healthcare Picks: Black Diamond Therapeutics (BDTX), Ultragenyx Pharmaceutical (RARE)
markets.businessinsider.com - October 17 at 10:28 AM
markets.businessinsider.com logoBlack Diamond Therapeutics (BDTX) Receives a Buy from Piper Sandler
markets.businessinsider.com - October 16 at 8:22 AM
finance.yahoo.com logoBlack Diamond Therapeutics Presents Dose Escalation Data Demonstrating Durable Responses in Patients with NSCLC from Phase 1 Trial of BDTX-1535
finance.yahoo.com - October 14 at 1:35 PM
msn.com logoBlack Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy
msn.com - October 12 at 9:45 AM
finance.yahoo.com logoBlack Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
finance.yahoo.com - October 4 at 2:07 PM
finance.yahoo.com logoCo-founder of cancer biotech Black Diamond replaced as CEO
finance.yahoo.com - September 18 at 1:35 PM
marketwatch.com logoBlack Diamond Therapeutics Chairman to Succeed Departing CEO
marketwatch.com - September 18 at 7:46 AM
finance.yahoo.com logoBlack Diamond Therapeutics Announces CEO Transition
finance.yahoo.com - September 18 at 7:46 AM
msn.com logoWedbush Reiterates Black Diamond Therapeutics (BDTX) Outperform Recommendation
msn.com - September 12 at 4:26 PM
markets.businessinsider.com logoPiper Sandler Keeps Their Buy Rating on Black Diamond Therapeutics (BDTX)
markets.businessinsider.com - August 14 at 10:38 AM
finanznachrichten.de logoBlack Diamond Therapeutics, Inc: Black Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finanznachrichten.de - August 11 at 6:18 PM
finance.yahoo.com logoBlack Diamond Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
finance.yahoo.com - August 11 at 6:18 PM
finance.yahoo.com logoBDTX - Black Diamond Therapeutics, Inc.
finance.yahoo.com - August 1 at 3:30 PM
marketbeat.com logoShort Interest in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Declines By 38.4%
marketbeat.com - July 28 at 8:58 AM
marketbeat.com logoBlack Diamond Therapeutics (NASDAQ:BDTX) Receives New Coverage from Analysts at Piper Sandler
marketbeat.com - July 14 at 8:21 AM
Get Black Diamond Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter.

I’m officially sounding the alarm. (Ad)

AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.

Just click here to watch my full uncensored interview.

BDTX Media Mentions By Week

BDTX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BDTX
News Sentiment

1.43

0.53

Average
Medical
News Sentiment

BDTX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BDTX Articles
This Week

3

1

BDTX Articles
Average Week

Get Black Diamond Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BDTX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BDTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners